Bank Of New York Mellon Corp Merrimack Pharmaceuticals Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

Shares

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$3.68 - $12.51 $275,558 - $936,748	74,880 New	74,880 $858,000
Q2 2022 Aug 15, 2022	SELL	$4.89 - $7.13 $220 - $320	-45 Reduced 0.11%	40,951 $244,000
Q2 2021 Aug 11, 2021	SELL	$6.04 - $7.77 $7,423 - $9,549	-1,229 Reduced 2.91%	40,996 $261,000
Q1 2021 May 13, 2021	BUY	$6.15 - $8.7 $151,794 - $214,733	24,682 Added 140.69%	42,225 $265,000
Q4 2020 Feb 09, 2021	BUY	$3.69 - $8.31 $114 - $257	31 Added 0.18%	17,543 $120,000
Q2 2020 Aug 12, 2020	BUY	$2.21 - $3.88 $2 - $3	1 Added 0.01%	17,512 $58,000
Q1 2020 May 06, 2020	SELL	$1.63 - $3.58 $195 - $429	-120 Reduced 0.68%	17,511 $37,000
Q1 2019 May 14, 2019	SELL	$3.19 - $5.73 $1,990 - $3,575	-624 Reduced 3.42%	17,631 $123,000
Q4 2018 Feb 11, 2019	SELL	$2.95 - $4.15 $73,201 - $102,978	-24,814 Reduced 57.61%	18,255 $70,000
Q2 2018 Aug 06, 2018	SELL	$3.86 - $7.61 $140,338 - $276,676	-36,357 Reduced 45.77%	43,069 $211,000
Q1 2018 May 15, 2018	SELL	$6.24 - $9.15 $4,892 - $7,173	-784 Reduced 0.98%	79,426 $639,000
Q4 2017 Feb 09, 2018	BUY	$7.99 - $11.87 $640,877 - $952,092	80,210	80,210 $822,000

Others Institutions Holding MACK

# of Institutions

2

Shares Held

349

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.